BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12644889)

  • 1. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.
    White DA; Holtzman SG
    Psychopharmacology (Berl); 2003 May; 167(2):203-10. PubMed ID: 12644889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of naltrexone after a single dose of morphine in the rat.
    Easterling KW; Holtzman SG
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1269-77. PubMed ID: 10027868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central discriminative effects of morphine in rats: training via intracerebroventricular administration.
    Easterling KW; Holtzman SG
    Brain Res Bull; 2001 Dec; 56(6):545-51. PubMed ID: 11786240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone.
    Bertalmio AJ; Woods JH
    Psychopharmacology (Berl); 1992; 106(2):189-94. PubMed ID: 1347952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further characterization of the discriminative stimulus effects of spiradoline.
    Holtzman SG
    Pharmacol Biochem Behav; 2000 Jul; 66(3):517-22. PubMed ID: 10899364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the discriminative stimulus effects of d-amphetamine by mu and kappa opioids in squirrel monkeys.
    Powell KR; Holtzman SG
    Pharmacol Biochem Behav; 2000 Jan; 65(1):43-51. PubMed ID: 10638635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discriminative stimulus effects of naloxone and naltrexone in morphine-treated rhesus monkeys: comparison of oral and subcutaneous administration.
    Gauthier CA; France CP
    Psychopharmacology (Berl); 1999 May; 144(2):131-6. PubMed ID: 10394993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of pentazocine as a discriminative stimulus in the squirrel monkey.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1982 Nov; 223(2):396-401. PubMed ID: 7131294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.
    France CP; de Costa BR; Jacobson AE; Rice KC; Woods JH
    J Pharmacol Exp Ther; 1990 Feb; 252(2):600-4. PubMed ID: 2156055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of naltrexone in the morphine-dependent rat.
    Gellert VF; Holtzman SG
    J Pharmacol Exp Ther; 1979 Dec; 211(3):596-605. PubMed ID: 574545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):195-202. PubMed ID: 3612524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists.
    Easterling KW; Holtzman SG
    J Pharmacol Exp Ther; 1997 Apr; 281(1):188-99. PubMed ID: 9103497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.
    Carey GJ; Bergman J
    J Pharmacol Exp Ther; 2001 Apr; 297(1):215-23. PubMed ID: 11259547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.